FDA NDC Directory · JSON-LD · Markdown

BESREMi

NDC 73536-500 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameROPEGINTERFERON ALFA-2B
Labeler / ManufacturerPharmaEssentia USA
Marketing categoryBiologic License Application · App BLA761166
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsROPEGINTERFERON ALFA-2B (500 ug/mL)
Marketing started20211112
Package count1

External sources

Source: openFDA. Public-domain (CC0).